Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) Gross Margin (2016 - 2025)

Jaguar Health (JAGX) has disclosed Gross Margin for 11 consecutive years, with 31.99% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 937.0% to 31.99% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 37.63% through Dec 2025, down 1779.0% year-over-year, with the annual reading at 67.21% for FY2025, 3302.0% up from the prior year.
  • Gross Margin for Q4 2025 was 31.99% at Jaguar Health, down from 35.23% in the prior quarter.
  • The five-year high for Gross Margin was 225.74% in Q4 2023, with the low at 14075.0% in Q1 2022.
  • Average Gross Margin over 5 years is 773.42%, with a median of 33.61% recorded in 2025.
  • The sharpest move saw Gross Margin tumbled -1240833bps in 2022, then skyrocketed 1407723bps in 2023.
  • Over 5 years, Gross Margin stood at 229.27% in 2021, then skyrocketed by 142bps to 95.72% in 2022, then skyrocketed by 136bps to 225.74% in 2023, then plummeted by -90bps to 22.63% in 2024, then surged by 41bps to 31.99% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 31.99%, 35.23%, and 17.19% for Q4 2025, Q3 2025, and Q2 2025 respectively.